Free Trial
NASDAQ:MLAB

Mesa Laboratories Q1 2026 Earnings Report

Mesa Laboratories logo
$91.36 -0.66 (-0.72%)
As of 03:40 PM Eastern

Mesa Laboratories EPS Results

Actual EPS
N/A
Consensus EPS
$2.46
Beat/Miss
N/A
One Year Ago EPS
N/A

Mesa Laboratories Revenue Results

Actual Revenue
N/A
Expected Revenue
$60.45 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Mesa Laboratories Announcement Details

Quarter
Q1 2026
Time
Before Market Opens
Conference Call Date
Tuesday, August 5, 2025
Conference Call Time
8:00AM ET

Conference Call Resources

Mesa Laboratories Earnings Headlines

Mesa Laboratories declares $0.16 dividend
MESA LABS DECLARES QUARTERLY DIVIDEND
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
See More Mesa Laboratories Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Mesa Laboratories? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Mesa Laboratories and other key companies, straight to your email.

About Mesa Laboratories

Mesa Laboratories (NASDAQ:MLAB) develops, manufactures, and distributes a diverse range of instruments and consumables designed to ensure quality control and safety in critical industrial, laboratory, and healthcare environments. The company’s product portfolio spans four primary business segments: BioScientific, Medical, Calibration, and Critical Care. Through these distinct operating units, Mesa offers biological indicator products for sterilization monitoring, anesthesia gas monitoring systems, precision temperature and pressure calibration equipment, and medical gas analysis solutions for hospitals and clinics.

Headquartered in Lakewood, Colorado, Mesa Laboratories was founded in the late 1960s and has grown through a combination of internal innovation and strategic acquisitions. Over the decades, the company has expanded its geographic footprint to serve customers in North America, Europe, Latin America, and the Asia-Pacific region. Mesa leverages an international network of manufacturing facilities, research and development centers, and distribution partners to support regulated industries that require rigorous safety and quality standards.

In its BioScientific segment, Mesa produces biological indicators and related consumables used primarily in healthcare and pharmaceutical sterilization processes. The Medical segment focuses on anesthesia gas monitoring and patient safety devices, while the Calibration segment supplies advanced temperature, pressure, and humidity calibration instruments for laboratory and industrial metrology applications. The Critical Care division delivers medical gas analyzers and verification systems that help hospitals meet stringent compliance and safety requirements.

Under the leadership of President and Chief Executive Officer Kenneth P. Roberts, Mesa Laboratories maintains a strong emphasis on product quality, regulatory compliance, and customer service. The company’s executive team brings extensive experience in life sciences, engineering, and global distribution. By investing in research and development and strengthening its international operations, Mesa Laboratories continues to address evolving market needs and support mission-critical processes across a wide array of end markets.

View Mesa Laboratories Profile

More Earnings Resources from MarketBeat